Treatment with Mecamylamine in Smoking and Non-Smoking Alcohol Dependent Patients

Conditions

Alcoholism

What is the purpose of this trial?

The purpose of the study will be to evaluate the efficacy of mecamylamine in reducing alcohol consumption in smoking and non-smoking alcohol dependent patients.

We hypothesize that mecamylamine will result in a greater reduction of alcohol consumption than placebo. We further hypothesize that mecamylamine will be effective in reducing both alcohol consumption and smoking in a subset of alcoholics who also smoke.


Participation Guidelines

Age:
18 Years - 60 Years
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
Elizabeth Ralevski
National Institute on Alcohol Abuse and Alcoholism
Dates:
02/12/2004
Last Updated:
Study HIC#:
0402026364